Posted inClinical Updates Hematology-Oncology news
Venetoclax Plus Azacitidine in Younger Adults with Acute Myeloid Leukemia: Evolving Evidence Beyond Historical Comparisons
Review of recent studies highlights venetoclax plus azacitidine as a feasible and effective therapy in younger AML patients, challenging standard intensive chemotherapy paradigms and suggesting a shift toward lower-intensity regimens with comparable or improved outcomes.